肝脏脑病变作为肝移植的说明或禁忌?
Mette Munk Lauridsen1,2, Jasmohan S Bajaj3
1Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, VA, USA.
Metabolic brain disease
|April 15, 2025
概括
肝脑病变 (HE) 是肝移植 (LT) 复杂的疾病. 积极的移植前管理和排除其他诊断对于在HE患者中取得成功的LT结果至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植医学 移植医学
- 神经科学是一个神经科学.
背景情况:
- 肝脑病变 (HE) 在肝移植 (LT) 中构成了重大挑战.
- 肝硬化症的严重程度可以表明晚期肝病和神经认知障碍,影响移植后的结果.
- 需要仔细考虑HE作为LT的指示与禁忌的作用.
研究的目的:
- 为肝病学家提供有关在LT候选人背景下评估HE的指导.
- 审查HE的移植前负担及其目前在移植清单中的地位.
- 讨论与LT相关的移植前和移植后的认知问题.
主要方法:
- 文献审查和专家共识综合.
- 对HE对肝病严重程度和神经认知功能影响的分析.
- 检查当前的肝移植上市标准和免疫抑制作用.
主要成果:
- 建议在移植前对HE进行积极的管理.
- 彻底排除神经退行性疾病和其他差异诊断是必要的.
- 由于免疫抑制剂造成的移植后认知问题需要密切监测.
结论:
- 高质量管理和准确的诊断对于LT的成功至关重要.
- 应该将HE严重性的客观测量整合到MELD得分中,以实现公平的移植分配.
- 对于HE患者来说,及时和适当的LT对于改善结果至关重要.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
796
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
796
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
344
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
344
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
261
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
261
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
348
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
348
Kidney Transplant I: Introduction
732
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
732


